USFDA completes PAI, GMP inspection at Dr. Reddy's Laboratories’ Andhra Pradesh facility

20 Jul 2023 Evaluate

United States Food & Drug Administration (USFDA) has completed a Pre-Approval Inspection (PAI) and a routine GMP inspection at Dr. Reddy's Laboratories’ API manufacturing facility in Srikakulam, Andhra Pradesh, India (CTO-6). The inspection was conducted from July 10, 2023 to July 19, 2023. The inspection closed with zero observations and a classification of No Action Indicated (NAI). 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1265.95 -2.65 (-0.21%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×